Innogene Kalbiotech at a Glance

A biotechnology company focusing on novel biologics, biosimilars and novel diagnostics. A part of Kalbe Group and a subsidiary company of PT Kalbe Genexine Biologics (KGbio).

Our Capabilities

What People Are Saying

Zhao Yanqing
President Director of Kexing Biopharm Co. Ltd

As a leading pharmaceutical enterprise in Southeast Asia, Innogene Kalbiotech (IGK) is one of our most important business partner in Southeast Asia, maintained a mutually beneficial relationship with us for about 20 years. IGK is a good partner with honest and practical style, I believe that we will continue to go hand in hand and expand the scope of cooperation in the future to make a contribution to Indonesia and the whole human health with the support of the friendship bridge between China and Indonesia.

Susheel Umesh
Chief Commercial Officer, Emerging Markets, Biocon Biologics

We are glad that through Kalbe we are able to address unmet needs of breast cancer patients through our affordable Trastuzumab which is a leading brand in its segment in Indonesia. We look forward to strengthening this synergistic partnership and expanding our product portfolio to enhance access to patients, in Indonesia.

Latest News